A Study of Intravenous Acetaminophen for Small Bowel Obstruction
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Mayo Clinic
- Study ID
- NCT05878015
- Phase
- PHASE4
- Status
- Enrolling By Invitation
Conditions
- Small Bowel Obstruction
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Acetaminophen — DRUG1000mg intravenous every 6 hours on day 1 and day 2. 1000mg intravenous every 8 hours on day 3 as needed.
Study Details
The purpose of this study is to compare IV Acetaminophen for pain control to the usual care with opioids in patients admitted for small bowel obstruction.
Key Dates
- Start date
- Oct 11, 2023
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 18 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: IV Acetaminophen GroupSubjects presented to emergency department (ED) and diagnosed with small bowel obstruction which receive IV acetaminophen
- No Intervention: Usual Care GroupSubjects presented to emergency department (ED) and diagnosed with small bowel obstruction will receive intravenous opioids per their provider's choice as standard of care.
Primary Outcome Measure
Resolution of small bowel obstruction [ Time Frame: 3 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic Florida | Jacksonville | Florida | 32224 | - |
Find similar trials in Jacksonville, FL
By research site